SHOULDER INNOVATIONS, INC. Investing Cash Flow
SHOULDER INNOVATIONS, INC. (SI) reported Investing Cash Flow of $17.32 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-06
- SHOULDER INNOVATIONS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $20.44M, a 184.30% increase year-over-year.
- SHOULDER INNOVATIONS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$3.12M.
- SHOULDER INNOVATIONS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$17.28M, a 573.48% decline year-over-year.
- SHOULDER INNOVATIONS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$72.44M, a 1577.08% decline year-over-year.
- SHOULDER INNOVATIONS, INC. net cash provided by (used in) investing activities for fiscal 2025 was -$95.60M, a 784.60% decline from fiscal 2024.
- SHOULDER INNOVATIONS, INC. net cash provided by (used in) investing activities for fiscal 2024 was $13.96M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $20.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $17.32M 10-Q · filed 2026-08-06 | $40.00K derived: sum of 3 quarters · filed 2026-08-06 | -$72.40M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$3.12M 10-Q · filed 2026-05-13 | -$20.40M derived: sum of 2 quarters · filed 2026-05-13 | -$92.84M derived: sum of 3 quarters · filed 2026-05-13 | -$85.65M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$17.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$89.72M derived: sum of 2 quarters · filed 2026-03-10 | -$82.53M derived: sum of 3 quarters · filed 2026-08-06 | -$95.60M 10-K · filed 2026-03-10 |
| 2025-09-30 | -$72.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$65.25M derived: sum of 2 quarters · filed 2026-08-06 | -$78.31M 10-Q · filed 2025-11-12 | -$74.67M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $7.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$5.88M 10-Q · filed 2026-08-06 | -$2.23M derived: sum of 3 quarters · filed 2026-08-06 | $2.67M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$13.07M 10-Q · filed 2026-05-13 | -$9.42M derived: sum of 2 quarters · filed 2026-05-13 | -$4.52M derived: sum of 3 quarters · filed 2026-05-13 | |
| 2024-12-31 | $3.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $8.55M derived: sum of 2 quarters · filed 2026-03-10 | $13.96M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $4.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $10.31M 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $5.41M 10-Q · filed 2025-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |